Associations Between Duration of Illicit Drug Use and Health Conditions: Results from the 2005-2007 National Surveys on Drug Use and Health

Annals of Epidemiology

Volumn 20, Issue 4, 2010, Pages 289-297

  Han, Beth ^a   Gfroerer, Joseph C ^a   Colliver, James D ^a  

^a SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

Author keywords

Duration of Illicit Drug Use; Health Conditions; Illicit Drug Use; National Survey on Drug Use and Health

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; PSYCHEDELIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANXIETY; ARTICLE; ASTHMA; BRONCHITIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG USE; HEALTH SURVEY; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG CANCER; PANCREATITIS; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SINUSITIS; TINNITUS; TUBERCULOSIS; UNITED STATES;

ADULT; AGE FACTORS; DRUG USERS; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HEROIN; HUMANS; LOGISTIC MODELS; MALE; MARIJUANA SMOKING; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; UNITED STATES;

EID: 77649342652     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.01.003     Document Type: Article

References (60)

1. Polen M.R., Sidney S., Tekawa I.S., Sadler M., and Friedman G.D. Health care use by frequent marijuana use smokers who do not smoke tobacco. West J Med 158 (1993) 596-601
2. Hollister L.E. Health aspects of cannabis. Pharmacol Rev 38 (1986) 1-20
3. Tashkin D.P. Pulmonary complications of smoked substance abuse. West J Med 152 (1990) 525-530
4. Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., and Muller J.E. Triggering myocardial infarction by marijuana. Circulation 102 (2001) 2805-2809
5. Khalsa J.H., Genser S., Francis H., and Martin B. Clinical consequences of marijuana. J Clin Pharmacol 42 11 Suppl (2002) 7s-10s
6. Klein T.W., Friedman H., and Specter S. Marijuana, immunity and infection. J Neuroimmunol 83 (1998) 102-115
7. Cregler L.L., and Mark H. Medical complications of cocaine abuse. N Engl J Med 315 (1986) 1495-1500
8. Schindler C.W., and Goldberg S.R. Cardiovascular effects of cocaine: underlying mechanisms. Drug Alcohol Depend 37 (1995) 181-182
9. Hollander J. The management of cocaine-associated myocardial ischemia. N Engl J Med 333 (1995) 1267-1272
10. Fessker R.D., Esshaki C.M., Stankewitz R.C., Johnson R.R., and Diaz F.G. The neurovascular complications of cocaine. Surg Neurol 47 (1997) 339-345
11. Mello N.K., and Mendelson J.H. Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav 57 (1997) 571-599
12. Chen K., Scheier L.M., and Kandel D.B. Effects of chronic cocaine use on physical health: a prospective study in a general population sample. Drug Alcohol Depend 43 (1996) 23-37
13. Reichlin S. Neuroendocrine-endocrine-immune interactions. N Engl J Med 329 (1993) 1246-1253
14. Friedman L.N., Williams M.T., Singh T.P., and Frieden T.R. Tuberculosis, AIDS, and death among substance abusers on welfare in New York city. N Engl J Med 334 (1996) 828-833
15. Theodorou S., and Haber P.S. The medical complications of heroin use. Curr Opin Psychiatry 18 (2005) 257-263
16. Garten R.J., Lai S., and Zhang J. Rapid transmission of hepatitis C virus among young injecting heroin users in southern China. Int J Epidemiol 33 (2004) 182-188
17. Everall I.P. Interaction between HIV and intravenous heroin abuse?. J Neuroimmunol 147 (2004) 13-15
18. Buttner A., Mall G., Penning R., and Weis S. The neuropathology of heroin abuse. Forensic Sci Int 113 (2000) 435-442
19. Rodgers J., Buchanan T., Pearson C., Parrott A.C., Ling J., Hefferman T.M., and Scholey A.B. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study. J Psychopharmacol 20 (2006) 437-446
20. Aghajanian G.K., and Marek G.J. Serotonin and hallucinogens. Neuropsychopharmacology 21 (1999) 16S-23S
21. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
22. National Institute on Drug Abuse (NIDA). NIDA InfoFacts: Hallucinogens-LSD, Peyote, Psilocybin, and PCP. Available at: http://www.nida.nih.gov/infofacts/hallucinogens.html. Accessed December 1, 2008.
23. Halpern J.H., and Pope H.G. Do hallucinogens cause residual neuropsychological toxicity?. Drug Alcohol Depend 53 (1999) 247-256
24. Acord L.D., and Barker D.D. Hallucinogenic drugs and cerebral deficit. J Nerv Ment Dis 156 (1973) 281-283
25. Culver C.M., and King F.W. Neuropsychological assessment of undergraduate marijuana and LSD users. Arch Gen Psychiatry 31 (1974) 707-711
26. Ridenour T.A. Inhalants: Not to be taken lightly anymore. Curr Opin Psychiatry 18 (2005) 243-247
27. Medina-Mora M.E., and Real T. Epidemiology of inhalant use. Curr Opin Psychiatry 21 (2008) 247-251
28. Freedenthal S., Vaughn M.G., Jenson J.M., and Howard M.O. Inhalant use and suicidality among incarcerated youth. Drug Alcohol Depend 90 (2007) 81-88
29. Soderberg L.S. Immunomodulation by nitrite inhalants may predispose abusers to AIDS and Kaposi's sarcoma. J Neuroimmunol 83 (1998) 157-161
30. Buchbinder S.P., Vittinghoff E., Heagerty P.J., Celum C.L., Seage G.R., Judson F.N., et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr 39 (2005) 82-89
31. Macleod J., Oaks R., Copello A., Crome I., Egger M., Hickman M., et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 363 (2004) 1579-1588
32. Resnick M.D., Bearman P.S., Blum R.W., Bauman K.E., Harris K.M., Jones J., et al. Protecting adolescents from harm: findings from the National Longitudinal Study on Adolescent Health. JAMA 278 (1997) 823-832
33. Dornbusch S.M., Lin I.-C., Munroe P.T., and Bianchi A.J. Adolescent polydrug use and violence in the United States. Int J Adolesc Med Health 11 (1999) 197-219
34. Kaesner R. New estimates of the effect of marijuana and cocaine use on wages. Indust Labor Relat Rev 47 (1994) 454-470
35. Greenwell L., and Brecht M. Self-reported health status among treated methamphetamine users. Am J Drug Alcohol Abuse 29 (2003) 75-104
36. Spinks R., Caspers K., Langbehn D., Yucuis R., McKirgan L.W., Arndt S., et al. Co-morbid health conditions at mid-life in the Iowa adoptees. Addict Behav 32 (2007) 991-1002
37. Adrian M., and Barry S.J. Physical and mental health problems associated with the use of alcohol and drugs. Subst Use Misuse 38 (2003) 1575-1614
38. National Institute on Drug Abuse (NIDA): Commonly abused drugs chart. Available at the NIDA web site: http://www.drugabuse.gov/DrugPages/DrugsofAbuse.html. Accessed April 1, 2009.
39. American Council for Drug Education (ACDE). Basic facts about drugs: Alcohol. Available at the ACDE web site: http://www.acde.org/common/alcohol.htm. Accessed April 1, 2009.
40. American Council for Drug Education (ACDE). Start with the fact: Tobacco. Available at the ACDE website: http://www.acde.org/common/Tobacco%202002.pdf. Accessed April 1, 2009.
41. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General (2004), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta
42. Rehm J., Graham K., Monteiro M., Gmel G., and Sempos C.T. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 98 (2003) 1209-1228
43. Alderdice F.A., and Davidson R. The effect of alcohol consumption on recency discrimination ability: an early screening test for alcohol-induced cognitive impairment. Br J Addict 85 (1990) 531-536
44. Harper C.G., and Kril J.J. Neuropathology of alcoholism. Alcohol Alcohol 25 (1990) 207-216
45. Reid M.C., Fiellin D.A., and O'Connor P.G. Hazardous and harmful alcohol consumption in primary care. Arch Intern Med 159 (1999) 1681-1689
46. Tenth Special Report to the United States Congress on Alcohol and Health. Medical consequences of alcohol abuse. Alcohol Research and Health 24 (2000) 27-31
47. Cornfield J., Haenszel W., Hammond E.C., Lilienfeld A.M., Shimkin M.B., and Wynder E.L. Smoking and lung cancer: recent evidence and a discussion of some questions. J Natl Cancer Inst 22 1 (1959) 173-203
48. National Cancer Institute. Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. Smoking and Tobacco Control Monograph No. 8 (1997), U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda (MD) NIH Publication No. 97-4213
49. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. Available at: http://www.oas.samhsa.gov/nsduh.htm. Accessed January 1, 2009.
50. Shah B, Barnwell B, Bieler G. SUDAAN User's Manual. Version 9.1 ed. Research Triangle Park (NC): Research Triangle Institute; 2005.
51. Clark H.W., Power A.K., Le Fauve C.E., and Lopez E.I. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat 34 (2008) 3-13
52. Sterk C.E., Theall K.P., and Elifson K.W. Who's getting the message? Intervention group response rates among women who inject drugs and/or smoke crack cocaine. Prev Med 37 (2003) 119-128
53. Friedmann P.D., McCullough D., and Saitz R. Screening and intervention for illicit drug abuse. Arch Intern Med 161 (2001) 248-251
54. McPherson T.L., and Hersch R.K. Brief substance use screening instruments for primary care settings: a review. J Subst Abuse Treat 18 (2000) 193-202
55. In: Harrison L., and Huges A. (Eds). The validity of self-reported drug use: improving the accuracy of survey estimates. NIDA Research Monograph 167, NIH Publication No. 97-4147 (1997), National Institute on Drug Use, Rockville (MD)
56. Bush T.L., Miller S.R., Golden A.L., and Hale W.E. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 79 (1989) 1554-1556
57. Paganini-Hill A., and Chao A. Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol 138 (1993) 101-106
58. Madow W.G. Net differences in interview data on chronic conditions and information derived from medical records. Vital Health Stat 57 (1973) 1-58
59. Han B., Gfroerer J.C., Colliver J.D., and Penne M.A. Substance use disorder among older adults in the United States in 2020. Addiction 104 (2009) 88-96
60. Johnson R.A., and Gerstein D.R. Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919. Am J Public Health 88 (1998) 27-33